© 2023 The American Journal of Medicine Blog. All Rights Reserved.
Inhaled corticosteroids
What's New from AJM
Inhaled Corticosteroids and the Risks of Diabetes Onset and Progression
In patients with respiratory disease, inhaled corticosteroid use is associated with modest increases in the risks of diabetes onset and diabetes progression. The risks are more pronounced at the higher doses currently prescribed in the treatment of chronic obstructive pulmonary disease.Abstract BackgroundSystemic corticosteroids are known to increase diabetes risk, but the effects of high-dose inhaled corticosteroids are unknown....
LATEST VIDEOS
Are Prisoners Good Hospital Patients?
01:59
Improving Care for Orthopedic Surgery Patients
00:41
Orthopedic Surgery + Internal Medicine Co-Management of Patients
01:28
We Need New Strategies to Prevent Lyme Disease
01:00
Patient Communication Strategies from an Italian Barber
01:00
Effects of Long COVID
00:54
Long COVID Brings Functional Limitations
01:24
Using Pet Scans to Diagnose Infections
00:35
Can We Blame Texting for Our Lack of Empathy?
01:00
GLP-1 + Glucose Blocker: Combo Therapy Improves Weight Loss & More
03:08
Should Statins Be Prescribed for Older Adults?
01:38
Pet Scan CT & Fever of Unknown Origin
02:14